Role of Tyrosine Kinases in Gastrointestinal Malignancies -

Role of Tyrosine Kinases in Gastrointestinal Malignancies (eBook)

eBook Download: PDF
2018 | 1st ed. 2018
XV, 241 Seiten
Springer Singapore (Verlag)
978-981-13-1486-5 (ISBN)
Systemvoraussetzungen
96,29 inkl. MwSt
  • Download sofort lieferbar
  • Zahlungsarten anzeigen

The aim of this book is to provide comprehensive overview of the role of different tyrosine kinases in the progression and metastasis of various cancers of the gastrointestinal tract such as esophagus, liver, pancreas, stomach, and colorectal. Activation of various signaling pathways and tyrosine kinases are responsible for resistance to chemo and radiotherapy in these gastrointestinal malignancies. Targeting these tyrosine kinases, which regulate the activities of survival pathways in growth, and metastasis is a rational strategy in gastrointestinal cancer therapy.

Each chapter embedded in this book covers information pertaining to a specific tyrosine kinase and its impact on various malignancies, which is not only significant for basic and clinical research investigations but will also be valued by students at advanced undergraduate to postgraduate levels.



Dr. Nagaraju GP is a faculty member in the Department of Hematology and Medical Oncology at Emory University School of Medicine. He obtained his MSc and his Ph.D., both in biotechnology, from Sri Venkateswara University, Tirupati, Andhra Pradesh, India. His research focuses on translational projects related to gastrointestinal malignancies. He has published over 65 research articles in highly reputed international journals and has presented more than 50 abstracts at various national and international conferences. He has also served as an editorial board member of several internationally recognized academic journals. He is an associate member of the Discovery and Developmental Therapeutics research program at Winship Cancer Institute. He has received several prestigious international awards and holds memberships with the Association of Scientists of Indian Origin in America (ASIOA), the Society for Integrative and Comparative Biology (SICB), the Science Advisory Board, The RNA Society, and the American Association of Cancer Research (AACR).


The aim of this book is to provide comprehensive overview of the role of different tyrosine kinases in the progression and metastasis of various cancers of the gastrointestinal tract such as esophagus, liver, pancreas, stomach, and colorectal. Activation of various signaling pathways and tyrosine kinases are responsible for resistance to chemo and radiotherapy in these gastrointestinal malignancies. Targeting these tyrosine kinases, which regulate the activities of survival pathways in growth, and metastasis is a rational strategy in gastrointestinal cancer therapy.Each chapter embedded in this book covers information pertaining to a specific tyrosine kinase and its impact on various malignancies, which is not only significant for basic and clinical research investigations but will also be valued by students at advanced undergraduate to postgraduate levels.

Dr. Nagaraju GP is a faculty member in the Department of Hematology and Medical Oncology at Emory University School of Medicine. He obtained his MSc and his Ph.D., both in biotechnology, from Sri Venkateswara University, Tirupati, Andhra Pradesh, India. His research focuses on translational projects related to gastrointestinal malignancies. He has published over 65 research articles in highly reputed international journals and has presented more than 50 abstracts at various national and international conferences. He has also served as an editorial board member of several internationally recognized academic journals. He is an associate member of the Discovery and Developmental Therapeutics research program at Winship Cancer Institute. He has received several prestigious international awards and holds memberships with the Association of Scientists of Indian Origin in America (ASIOA), the Society for Integrative and Comparative Biology (SICB), the Science Advisory Board, The RNA Society, and the American Association of Cancer Research (AACR).

Chapter 1. 1.  Overview of tyrosine kinases and their receptors in gastrointestinal malignancies- .- Chapter 2. EGFR and Erb-B2R (HER2): their role in Esophagus cancer.- Chapter 3. HGFR and FGFR2: their role in progression and metastasis  of Esophagus cancer.- Chapter 4. Role of Src and VEGF R tyrosine kinases in Esophagus cancer.- Chapter  5. HGF receptor tyrosine kinase in gastric cancer. - Chapter  6. The EGF/ErbB receptor family of tyrosine kinases in gastric cancer.- Chapter  7. Helicobacter pylori CagA protein: its role and interaction tyrosine kinases in gastric cancer.- Chapter 8. RON receptor tyrosine kinase in pancreatic cancer progression.- Chapter 9. EGFR and Cytoplasmic kinases Src targeting in pancreatic cancer.- Chapter 10. VEGF and PDGFR targeting in pancreatic cancer.- Chapter 11. c-KIT, and FLT-3: their role in Hepatocellular carcinoma.- Chapter 12. VEGFR, and PDGFR: their targeting in Liver Cancer.- Chapter 13. EGFR and FGFR in growth and metastasis of colorectal cancer.- Chapter 14. VEGFR, and PDGFR: their targeting in colorectal cancerm.- Chapter 15. Nano materials and their impact on tyrosine kinase on selected gastrointestinal malignancies.- Chapter 16. Tyrosine kinase inhibitors and their clinical prospective in gastrointestinal malignancies.- Chapter 17. Drug resistance against tyrosine kinase inhibitors in gastrointestinal malignancies.- Chapter 18. Tyrosine kinases: their expression, diagnostic, therapeutic and prognostic aspects in gastrointestinal cancers.

Erscheint lt. Verlag 27.9.2018
Zusatzinfo XV, 241 p. 28 illus., 21 illus. in color.
Verlagsort Singapore
Sprache englisch
Themenwelt Medizinische Fachgebiete Innere Medizin Gastroenterologie
Medizin / Pharmazie Medizinische Fachgebiete Onkologie
Studium 2. Studienabschnitt (Klinik) Humangenetik
Naturwissenschaften Biologie Biochemie
Schlagworte drug resistance • Gastrointestinal Malignancies • gene expression • receptors • tyrosine kinase inhibitors • tyrosine kinase receptors • tyrosine kinases
ISBN-10 981-13-1486-1 / 9811314861
ISBN-13 978-981-13-1486-5 / 9789811314865
Haben Sie eine Frage zum Produkt?
PDFPDF (Wasserzeichen)
Größe: 4,8 MB

DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasser­zeichen und ist damit für Sie persona­lisiert. Bei einer missbräuch­lichen Weiter­gabe des eBooks an Dritte ist eine Rück­ver­folgung an die Quelle möglich.

Dateiformat: PDF (Portable Document Format)
Mit einem festen Seiten­layout eignet sich die PDF besonders für Fach­bücher mit Spalten, Tabellen und Abbild­ungen. Eine PDF kann auf fast allen Geräten ange­zeigt werden, ist aber für kleine Displays (Smart­phone, eReader) nur einge­schränkt geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich